ALYSSA COMERFORD: Open Payments
NPI 1952173932 · CHESTERTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,348 in 110 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $424 · 2025 $2,348
Food & beverage: $2,016Education: $332
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $392 |
| Galderma Laboratories, L.P. | 7 | $281 |
| Janssen Biotech, Inc. | 6 | $259 |
| UCB, Inc. | 13 | $244 |
| Novartis Pharmaceuticals Corporation | 9 | $238 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $165 |
| PFIZER INC. | 9 | $163 |
| Incyte Corporation | 8 | $149 |
| GENZYME CORPORATION | 5 | $138 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
Products named: NEMLUVIO, SKYRIZI, TREMFYA, Bimzelx, DUPIXENT, OPZELURA, CIBINQO, ILUMYA.
Industry payments across IN — which companies pay providers there.
